Therapy for memory and attention impairments in young patients
Objective. To study the efficacy and tolerance of tanakan in the treatment of mild cognitive impairment in young patients. Patients and methods. The study enrolled 30 patients whose mean age was 33.5±7.5 years. It used clinical neurological examination; a test for rating general condition, activity,...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2013-11-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/248 |
_version_ | 1797876498646958080 |
---|---|
author | Elena Glebovna Filatova M V Naprienko |
author_facet | Elena Glebovna Filatova M V Naprienko |
author_sort | Elena Glebovna Filatova |
collection | DOAJ |
description | Objective. To study the efficacy and tolerance of tanakan in the treatment of mild cognitive impairment in young patients. Patients and methods. The study enrolled 30 patients whose mean age was 33.5±7.5 years. It used clinical neurological examination; a test for rating general condition, activity, and mood; studies to evaluate aural short-term and verbal short-term memories and to estimate the level of attention using Schulte's tables, and questionnaires for the rating of autonomic disorders and nocturnal sleep quality, those for the patient subjective assessment of treatment efficiency and for the recording of adverse reactions. Results. Tanakan therapy led to the normalized emotional status in the patients, improved nocturnal sleep, and reduced autonomic disorders. There was a tendency towards improvement of all characteristics of attention. Aural and verbal memories became better. Conclusion. Tanakan is an effective and safe drug to treat cognitive impairment at any age. |
first_indexed | 2024-04-10T02:04:13Z |
format | Article |
id | doaj.art-7c08c976529642f99b51aa90d4e31dd5 |
institution | Directory Open Access Journal |
issn | 2074-2711 2310-1342 |
language | Russian |
last_indexed | 2024-04-10T02:04:13Z |
publishDate | 2013-11-01 |
publisher | IMA-PRESS LLC |
record_format | Article |
series | Неврология, нейропсихиатрия, психосоматика |
spelling | doaj.art-7c08c976529642f99b51aa90d4e31dd52023-03-13T08:42:13ZrusIMA-PRESS LLCНеврология, нейропсихиатрия, психосоматика2074-27112310-13422013-11-0153182310.14412/2074-2711-2013-2334248Therapy for memory and attention impairments in young patientsElena Glebovna Filatova0M V Naprienko1Academician Aleksandr Vein Clinic of Headache and Autonomic DisordersAcademician Aleksandr Vein Clinic of Headache and Autonomic DisordersObjective. To study the efficacy and tolerance of tanakan in the treatment of mild cognitive impairment in young patients. Patients and methods. The study enrolled 30 patients whose mean age was 33.5±7.5 years. It used clinical neurological examination; a test for rating general condition, activity, and mood; studies to evaluate aural short-term and verbal short-term memories and to estimate the level of attention using Schulte's tables, and questionnaires for the rating of autonomic disorders and nocturnal sleep quality, those for the patient subjective assessment of treatment efficiency and for the recording of adverse reactions. Results. Tanakan therapy led to the normalized emotional status in the patients, improved nocturnal sleep, and reduced autonomic disorders. There was a tendency towards improvement of all characteristics of attention. Aural and verbal memories became better. Conclusion. Tanakan is an effective and safe drug to treat cognitive impairment at any age.https://nnp.ima-press.net/nnp/article/view/248cognitive impairmentsemotional statustanakan |
spellingShingle | Elena Glebovna Filatova M V Naprienko Therapy for memory and attention impairments in young patients Неврология, нейропсихиатрия, психосоматика cognitive impairments emotional status tanakan |
title | Therapy for memory and attention impairments in young patients |
title_full | Therapy for memory and attention impairments in young patients |
title_fullStr | Therapy for memory and attention impairments in young patients |
title_full_unstemmed | Therapy for memory and attention impairments in young patients |
title_short | Therapy for memory and attention impairments in young patients |
title_sort | therapy for memory and attention impairments in young patients |
topic | cognitive impairments emotional status tanakan |
url | https://nnp.ima-press.net/nnp/article/view/248 |
work_keys_str_mv | AT elenaglebovnafilatova therapyformemoryandattentionimpairmentsinyoungpatients AT mvnaprienko therapyformemoryandattentionimpairmentsinyoungpatients |